Seven Fleet Capital Management LP - 30 Sep 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager: Seven Fleet Capital Management LP
Reporting Manager: Seven Fleet Master Fund LP
Security: CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol: CTMX
Disclosed Ownership: 48.9K shares
Ownership: 0.02%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 12:04:30 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Seven Fleet Master Fund LP	0.02%	48.9K	48.9K	/s/ Dr. Brian Liu	Dr. Brian Liu, Managing Member of Seven Fleet Capital Management LP, its Investment Mgr and Seven Fleet Capital Management GP, LLC, its Gen'l Ptr
Seven Fleet Capital Management LP	0.02%	48.9K	48.9K	/s/ Dr. Brian Liu	Dr. Brian Liu , Managing Member of Seven Fleet Capital Management GP, LLC, its General Partner
Seven Fleet Capital Management GP LLC	0.02%	48.9K	48.9K	/s/ Dr. Brian Liu	Dr. Brian Liu, Managing Member
Brian Liu	0.02%	48.9K	48.9K	/s/ Dr. Brian Liu	Dr. Brian Liu